Active, Not Recruiting
IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)
NCT05155254
- Conditions
- Melanoma, Metastatic Melanoma, Neoplasms, +11 more
- Locations
-
- Mid Florida Hematology and Oncology Center Orange City, Florida, United States
- Orlando Health Cancer Institute Orlando, Florida, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
- VCU Massey Cancer Center Richmond, Virginia, United States